Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

CARM Financial Statements and Analysis

NASDAQ : CARM

Carisma Therapeutics, Inc.

$0.33
-0.0278-7.77%
At Close 4:00 PM
64.84
BESG ScoreESG Rating

CARM FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

CARM Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

DateSep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue3.385M9.197M3.397M4.289M3.827M
cost of revenue0255.00K1.693M2.084M695.00K
gross profit3.385M8.942M1.704M2.205M3.132M
gross profit ratio1.000.9720.5020.5140.818
research and development expenses11.326M15.307M17.462M19.415M19.551M
general and administrative expenses5.203M5.56M5.445M7.324M6.62M
selling and marketing expenses0-255.00K-1.693M-2.084M0
selling general and administrative expenses5.203M5.305M3.752M5.24M6.62M
other expenses0-15.307M000
operating expenses16.529M20.612M21.214M24.655M26.171M
cost and expenses16.529M20.867M22.907M26.739M26.171M
interest income0001.295M941.00K
interest expense0508.00K532.00K00
depreciation and amortization737.00K255.00K1.693M2.084M695.00K
ebitda-12.407M-11.415M-17.817M-20.366M-22.344M
ebitda ratio-3.665-1.241-5.245-4.748-5.839
operating income-13.144M-11.67M-19.51M-22.45M-22.344M
operating income ratio-3.883-1.269-5.743-5.234-5.839
total other income expenses net442.00K508.00K532.00K1.295M941.00K
income before tax-12.702M-11.162M-18.978M-21.155M-21.403M
income before tax ratio-3.752-1.214-5.587-4.932-5.593
income tax expense001.65M-197.00K-695.00K
net income-12.702M-11.162M-18.978M-20.958M-21.403M
net income ratio-3.752-1.214-5.587-4.886-5.593
eps-0.31-0.27-0.46-0.52-0.53
eps diluted-0.31-0.27-0.46-0.52-0.53
weighted average shs out41.544M41.544M40.938M40.392M40.286M
weighted average shs out dil41.544M41.544M40.938M40.392M40.286M
Graph

CARM Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

DateSep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents26.881M40.362M56.515M77.605M83.132M
short term investments01.548M1.548M011.005M
cash and short term investments26.881M40.362M56.515M77.605M94.137M
net receivables02.00M000
inventory00000
other current assets7.256M9.084M4.438M2.866M3.428M
total current assets34.137M50.721M60.953M80.471M97.565M
property plant equipment net7.713M8.476M12.70M8.937M9.043M
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments000030.00K
tax assets00000
other non current assets208.00K142.00K141.999K145.999K146.00K
total non current assets7.921M8.618M12.842M9.083M9.219M
other assets001.001.000
total assets42.058M59.339M73.795M89.554M106.784M
account payables1.728M2.033M2.166M3.933M2.409M
short term debt2.46M4.924M3.864M1.935M1.388M
tax payables0000197.00K
deferred revenue682.00K659.00K1.189M1.413M1.185M
other current liabilities5.688M8.001M5.922M8.627M7.969M
total current liabilities10.558M15.617M13.141M15.908M12.951M
long term debt857.00K1.297M3.628M1.188M1.359M
deferred revenue non current041.25M45.00M45.00M45.00M
deferred tax liabilities non current0-1.00000
other non current liabilities41.769M815.00K1.131M926.00K1.176M
total non current liabilities42.626M43.362M49.759M47.114M47.535M
other liabilities01.00000
capital lease obligations3.317M1.297M3.628M1.188M2.747M
total liabilities53.184M58.979M62.90M63.022M60.486M
preferred stock01.00000
common stock41.00K41.00K41.00K40.00K40.00K
retained earnings-287.944M-275.242M-264.08M-245.102M-224.144M
accumulated other comprehensive income loss0000373.00K
other total stockholders equity276.777M275.561M274.934M271.594M270.029M
total stockholders equity-11.126M360.00K10.895M26.532M46.298M
total equity-11.126M360.00K10.895M26.532M46.298M
total liabilities and stockholders equity42.058M59.339M73.795M89.554M106.784M
minority interest00000
total investments01.548M1.548M011.005M
total debt3.317M3.759M7.492M3.123M2.747M
net debt-23.564M-36.603M-49.023M-74.482M-80.385M
Graph

CARM Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

DateSep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
deferred income tax000-3.222M-172.00K
stock based compensation1.487M625.00K1.057M873.00K848.00K
change in working capital-12.711M-8.966M-7.86M2.09M-2.399M
accounts receivables2.00K0000
inventory00000
accounts payables-5.77M-74.00K-1.826M1.819M-287.00K
other working capital-6.348M-8.892M-6.034M270.999K-2.112M
other non cash items-8.856M4.337M7.932M2.89M1.432M
net cash provided by operating activities-28.712M-16.12M-22.425M-16.243M-20.999M
investments in property plant and equipment12.00K-106.00K-17.00K-561.00K-189.00K
acquisitions net00000
purchases of investments49.696M0000
sales maturities of investments-31.075M0011.00M30.00M
other investing activites-74.925M0000
net cash used for investing activites-56.292M-106.00K-17.00K10.439M29.811M
debt repayment-1.99M-413.00K-1.319M-150.00K-938.00K
common stock issued-28.226M2.00K2.288M95.00K40.00K
common stock repurchased00000
dividends paid00000
other financing activites-36.563M-342.00K383.00K156.00K-1.135M
net cash used provided by financing activities-66.779M73.00K1.352M247.00K-2.033M
effect of forex changes on cash00029.999K0
net change in cash-35.926M-16.153M-21.09M-5.527M6.779M
cash at end of period26.881M40.362M56.515M77.605M83.162M
cash at beginning of period62.807M56.515M77.605M83.132M76.383M
operating cashflow-28.712M-16.12M-22.425M-16.243M-20.999M
capital expenditure12.00K-106.00K-17.00K-561.00K-189.00K
free cash flow-28.70M-16.226M-22.442M-16.804M-21.188M
Graph

Frequently Asked Questions

How did Carisma Therapeutics, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?
A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, CARM generated $3.39M in revenue last quarter, while its costs came in at $0.00.
Last quarter, how much Gross Profit did Carisma Therapeutics, Inc. report?
A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Carisma Therapeutics, Inc. reported a $3.39M Gross Profit for the quarter ended Sep 30, 2024.
Have CARM's Total Operating Expenses and Operating Income been favorable recently?
Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. CARM incurred $16.53M worth of Operating Expenses, while it generated -$13.14M worth of Operating Income.
How much Net Income has CARM posted recently?
The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Carisma Therapeutics, Inc., the company generated -$12.70M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.
At the end of the last quarter, how much Cash and Equivalents did Carisma Therapeutics, Inc. have?
The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Carisma Therapeutics, Inc. as of the end of the last quarter was $26.88M.
What are CARM's Total Net Receivables for the last quarter?
Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, CARM had Total Net Receivables of $0.00.
In terms of Total Assets and Current Assets, where did Carisma Therapeutics, Inc. stand at?
An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of CARM were $34.14M, while the Total Assets stand at $42.06M.
As of the last quarter, how much Total Debt did Carisma Therapeutics, Inc. have?
The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of CARM's debt was $3.32M at the end of the last quarter.
What were CARM's Total Liabilities during the last reported quarter?
A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, CARM reported total liabilities of $53.18M.
How much did CARM's Working Capital change over the last quarter?
Working Capital Change for CARM was -$12.71M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.
CARM generated how much cash from operating activities?
An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. CARM generated -$28.71M of Cash from Operating Activities during its recently reported quarter.
What was CARM's latest reported Net Change in Cash?
An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. CARM reported a -$35.93M Net Change in Cash in the most recent quarter.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph